Yearly zoledronic acid in postmenopausal osteoporosis.

Yearly zoledronic acid in postmenopausal osteoporosis.

Detaylı Bibliyografya
Asıl Yazarlar:	Poole, K, Kaptoge, S, Reeve, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2007

Benzer Materyaller

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
Yazar:: O V Yakushevskaya, ve diğerleri
Baskı/Yayın Bilgisi: (2012-08-01)

Treatment of postmenopausal osteoporosis, patient perspectives &ndash; focus on once yearly zoledronic acid
Yazar:: Raj Carmona, ve diğerleri
Baskı/Yayın Bilgisi: (2009-07-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
Yazar:: Lin H, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Risk factors analysis in postmenopausal osteoporosis fragility fracture patients after treated with zoledronic acid
Yazar:: Ding Yue, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
Yazar:: Fernanda Martins Gazoni, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis
Yazar:: L.V. Host, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
Yazar:: Fatemeh Rostami-Golmohammadi, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
Yazar:: Räkel A, ve diğerleri
Baskı/Yayın Bilgisi: (2011-03-01)

Zoledronic acid infusion for prevention and treatment of osteoporosis
Yazar:: John A Sunyecz
Baskı/Yayın Bilgisi: (2010-10-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
Yazar:: Nataliya Vladimirovna Toroptsova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
Yazar:: Nataliya Vladimirovna Toroptsova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
Yazar:: Deepak Kumar Khajuria, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study
Yazar:: Feyzi Gokosmanoglu, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
Yazar:: Paul K Piper Jr, ve diğerleri
Baskı/Yayın Bilgisi: (2009-06-01)

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
Yazar:: Leslie Spangler, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
Yazar:: Ruxu You, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
Yazar:: Federica Bellone, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

How zoledronic acid improves osteoporosis by acting on osteoclasts
Yazar:: Biao Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
Yazar:: S Yu Vorotnikova, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Generic zoledronic acid for osteoporosis: focus on tolerability and safety
Yazar:: N. V. Toroptsova, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Role of zoledronic acid in treatment of osteoporosis and prevention of fractures
Yazar:: A. V. Krivova, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Zoledronate prevents bone loss after stroke
Yazar:: Poole, K, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

The effects of zoledronate on iliac bone remodelling in stroke patients
Yazar:: Poole, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
Yazar:: Ege Can Serefoglu, ve diğerleri
Baskı/Yayın Bilgisi: (2010-05-01)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
Yazar:: Luca Dalle Carbonare, ve diğerleri
Baskı/Yayın Bilgisi: (2010-08-01)

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
Yazar:: Irina Aleksandrovna Baranova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-09-01)

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
Yazar:: Irina Aleksandrovna Baranova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-09-01)

Preserving hip bone mineral density following stroke using intravenous zoledronic acid: Findings from a 1 year randomised controlled trial
Yazar:: Poole, K, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Pathogenesis and treatment of postmenopausal osteoporosis
Yazar:: Milhaud, G, ve diğerleri
Baskı/Yayın Bilgisi: (1983)

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
Yazar:: Weilong Li, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
Yazar:: Asif Hussain, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond
Yazar:: Alexandru Florin Florescu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
Yazar:: Sanjay Agarwala, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
Yazar:: Jun Xie, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
Yazar:: Johann D Ringe
Baskı/Yayın Bilgisi: (2010-06-01)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
Yazar:: Rol, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

EFFECT OF ZOLEDRONIC ACID THERAPY ON FRACTURE RISK IN THE TREATMENT OF MEN WITH OSTEOPOROSIS
Yazar:: Steven Boonen, ve diğerleri
Baskı/Yayın Bilgisi: (2012-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
Yazar:: Huang CF, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

The effects of zoledronate on iliac bone remodelling; a histomorphometric study in stroke patients
Yazar:: Poole, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
Yazar:: F. Bertoldo, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)